Emergency Control of the Acutely Disturbed Adult Patient GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION...

Similar documents
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Rapid Tranquillisation for adolescent, adults and older people Medicines management team July 2014

Guidance for Drug Treatment of Acute Behavioural Disturbance (Rapid Tranquillisation)

Guideline for use of Intramuscular Medication for Acutely Disturbed Behaviour in Mental Health and Associated Services

Management of Severe Agitation

Northumbria Healthcare NHS Foundation Trust. Your guide to understanding Delirium. Issued by Department of Medicine

This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.

Mouth care for people with dementia. Delirium (Confusion) Understanding changes in behaviour in dementia

1. GUIDELINES FOR THE MANAGEMENT OF AGITATION IN ADVANCED CANCER

Assessment of physical monitoring following rapid tranquillisation. Stephen Dye

Unless this copy has been taken directly from the Trust intranet site (Pandora) there is no assurance that this is the most up to date version

Guideline for the Identification and Management of Delirium (Including use of the THINK DELIRIUM Support Tool)

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

The Rapid Tranquillization Policy. (including the use of oral PRN medication) (Replaces Policy No. 198/Clinical)

MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life

Keep Calm and Carry On Management of the Agitated Patient in the ED 29TH ANNUAL UPDATE IN EMERGENCY MEDICINE FEBRUARY 21-24, 2016

Education. How to deal with violent and aggressive patients in acute medical settings

Delirium. Information for patients, relatives and carers. Nursing and Patient Experience. Royal Surrey County Hospital. Patient information leaflet

Rapid Tranquillisation Policy

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

Controlled Document Number: Version Number: 1. Controlled Document Sponsor: Controlled Document Lead (Author): On: July Review Date: July 2020

the general hospital: case discussions

Rapid Tranquilisation and the Management of Violent and Aggressive Paediatric Patients

SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]

SPAGG. Coversheet for Specialist Palliative Audit and Guideline Group Agreed Documentation

Delirium. Dr. John Puxty

DELIRIUM. Approach and Management

Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA)

Community Paediatric Policy for minimal sedation

Rapid Tranquilisation Policy

Sedation Guidelines for Air Ambulance Transfer of Psychiatric Patients

This information explains the advice about supporting people with dementia and their carers that is set out in NICE SCIE clinical guideline 42.

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005

Delirium. Patient Information Leaflet

Critical Care Pharmacological Management of Delirium

Delirium in Hospital Care

Delirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us

Paediatric Assessments

Symptom Management Pocket Guides: DELIRIUM

Mouth care for people with dementia. False beliefs and delusions in dementia. Caring for someone with dementia

Delirium: Information for Patients and Families

DELIRIUM Bridging the gap in Doctors Education

National Audit of Dementia

Delirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018

ALCOHOL WITHDRAWAL GUIDELINES

Drugs used to relieve behavioural and psychological symptoms in dementia

2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust

Schizophrenia: core interventions in the treatment and management of schizophrenia

Caring for someone who has self-harmed or had suicidal thoughts. A family guide

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Palliative Care Emergencies. Additional module if needed

Delirium. Assessment and Management

SECTION 7: BECOMING CONFUSED AFTER AN OPERATION

Insomnia Management Guideline

Buccal Midazolam For the treatment of prolonged epileptic seizures, clusters of epileptic seizures and status epilepticus.

Chapter 20 Psychiatric Emergencies Introduction Myth and Reality Defining Behavioral Crisis (1 of 3) Defining a Behavioral Crisis (2 of 3)

Declaration of disclosure. Objectives. Did you know... ED Environment

Cardiac Catheter Labs Intravenous Drug Therapy Guide

Guidelines for the use of Zuclopenthixol Acetate (Clopixol Acuphase ) injection. Version 1

Care of the Acutely Agitated Patient. Objectives. Agitation Defined

Benzodiazepines and Hypnotics

2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust

Care in the Last Days of Life

Shared Care Guideline for Olanzapine (Zyprexa )

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Renal Palliative Care Last Days of Life

patient group direction

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

End of end of life care in dementia opportunities for quality improvement

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta

Sedation in Children

2010 National Audit of Dementia (Care in General Hospitals) Chelsea and Westminster Hospital NHS Foundation Trust

PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF ORAL DIAZEPAM TO WORKING AGE AND OLDER PEOPLE IN THE COMMUNITY

Psychiatric Emergencies and Psychotropic Medication

Restraint and the Mental Capacity Act 2005 in operational policing Mental Health & Policing Briefing Sheet 4

The Psychiatric Liaison Team for Older Adults

Taking Care of Yourself and Your Family After Self-Harm or Suicidal Thoughts A Family Guide

patient group direction

PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE

Advice for healthcare professionals in any setting

This factsheet covers:

Managing Behavioural Problems in Patients with Learning Disabilities

Managing presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

in North East Lincolnshire Care Trust Plus Implementation Plan Executive Summary

SAMPLE. This direction was authorised on 4/5/2007. The direction will be reviewed by 4/5/2009

Management of the Agitated and Violent ED Patient. Lauren Klein, MD, MS Faculty Physician Hennepin County Medical Center Minneapolis, Minnesota

The challenges faced by people with a stoma and dementia

Seeking Consent: Working with People in Prison

Agitation. Susan Emmens Palliative Care Clinical Nurse Specialist

Westminster Memory Services Pathways Toolkit (updated October 2016)

MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

End of life prescribing guidance

GUIDELINES FOR THE MANAGEMENT OF DELIRIUM IN ADVANCED CANCER

Psychiatric Emergencies and ER Violence

Psychosis with coexisting substance misuse

Critical Care Pharmacological Management of Delirium

Transcription:

Delirium Toolkit Emergency Control of the Acutely Disturbed Adult Patient Table of Contents GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT... 2 ACTION... 2 AFTERCARE... 3 NOTES... 4 Rob Morris Bev Brady First Edition November 2012

GUIDELINES ON EMERGENCY CONTROL OF THE ACUTELY DISTURBED ADULT PATIENT These guidelines are for use when a patient is acutely, and severely, disturbed, that is, physically aggressive, or threatening to become so, a danger to him or herself, staff, visitors or other patients, or exhibiting behaviour disruptive to the functioning of the ward, and with a presumed medical or psychiatric cause. Consent is generally required for treatment. If the patient is not competent to give or refuse consent (see notes 1 and 2), act on your judgement of what is in the patient s best interest. Think of the possibility of a treatable medical cause for the disturbance (e.g. hypoglycaemia, pain, hypoxia, urinary retention). For guidance only rigid adherence may not be appropriate. Seek more senior advice, at any stage, if in doubt. ACTION 1. Use non-drug measures first. Remain calm and do not get angry (it never helps). Avoid direct confrontation and provocation. Find out what is worrying the patient and what they want done about it. Offer to help. Reassure patient that he or she is not going to be harmed. Negotiate a return to room/chair/bed or try distraction (watch TV, have a drink). If necessary, use physical restraint - the minimum practicable for the minimum length of time. Call Security to assist with restraint if required. 2. Offer oral medication, preferably in liquid form, HALOPERIDOL 5 mg, or LORAZEPAM 2 mg (crush tablets and dissolve in a small volume of water). Halve doses if elderly and frail. 3. If rapid, parenteral, sedation with drugs is required look at the table. Use your clinical judgement to decide what category of patient you are dealing with. 4. Get the patient safely restrained. Give first suggested drug intramuscularly. Wait 20-30 minutes. If no, or inadequate, response give second suggested drug. Repeat these at intervals of 20-30 minutes until control is achieved or maximum dose is reached. 5. If control has not been achieved 30 minutes after reaching maximum doses, inform a consultant. Transfer to High Dependency Unit (or resuscitation room if in A&E). Patient group Try first Try second Maximum dose in first 24h ** Highly aroused, physically robust adult, including those already on antipsychotic drugs Lorazepam 2mg Repeat, then try haloperidol 5mg* Lorazepam 4mg haloperidol 12mg *** Alcohol withdrawal Lorazepam 2mg Repeat Lorazepam 8mg Frail older people or severe respiratory disease Haloperidol 2.5mg Lorazepam 0.5-1mg Haloperidol 10mg Lorazepam 4mg Dementia with Lewy bodies Lorazepam 0.5-1mg Repeat Lorazepam 4mg Delirium Haloperidol 2.5mg Repeat Haloperidol 12mg *** Table: Rapid tranquilisation. Offer oral medication first. The drugs in the table are given intramuscularly, following safe physical restraint, with doses at 20-30 minute intervals until adequate effect is achieved or maximum dose is reached. * NICE guidance recommends combining haloperidol with promethazine 25-50mg i.m.; maximum 100mg in 24h; the evidence for this is quite weak, and the injection is painful ** British National Formulary (BNF) maximums should only be exceeded if clinically necessary, and after review by a senior doctor. If control is not achieved with maximum doses consult a senior doctor. Consider i.v. midazolam 1-2mg boluses at 2 minute intervals maximum 20mg. Move to critical care *** The Summary of Product Characteristics for i.m. haloperidol gives a maximum of 18mg/day. The BNF recommends a maximum of 12mg/day. At the time of writing the discrepancy has not been resolved.

AFTERCARE Nurse in a light and quiet room. Separate from other patients. Nursing observation should be appropriate to the level of sedation. Nurse in the recovery position, and continue to observe respiratory rate and oxygen saturation. Once awake, offer glasses and hearing aid, if worn. A diagnosis for the behavioural disturbance must be made, and the underlying cause treated. Consider drugs (including illicit substances), alcohol, hypoglycaemia, infection, metabolic disturbance, acute neurological disease (including trauma, infections, vascular and spaceoccupying lesions), pain, urinary retention, constipation. Urgently get a third party history of previous psychiatric problems and previous cognitive function (use the phone; relatives, GP). Medical staff involved in the decision to undertake emergency sedation must arrange for the patient to be reviewed by the responsible consultant as soon as possible (within 4 hours) after the use of emergency sedation. If the consultant is not available, then review by a suitable deputy (Specialist Registrar or Associate Specialist) must be undertaken within 4 hours. If the patient is not under the direct medical care of a geriatrician, there is a geriatrician on call (Ext 62511) who is available for advice. In any event further assistance and guidance ( in hours ) is available through the Rapid Response Liaison Psychiatry service (Department of Psychological Medicine) call Ext 63885. Record the treatment given, and the basis of the decisions taken, in the medical notes. Consider the need for starting or increasing regular oral medication before emergency sedation wears off. Be wary, however, of regular sedation without a good explanation of what is going on medically. Review all sedative drugs daily. BE CAREFUL. READ THE NOTES OVER THE PAGE. YOU MAY BE UNFAMILIAR WITH THE DRUGS USED.

NOTES 1. Capacity for consent requires that an adult (18 years of age or over) can understand the purpose, nature and effects of the proposed treatment, including adverse effects and the consequences of refusal; retain the information; weigh up and make a judgement about it; and communicate a decision. Capacity can be lost temporarily for psychological reasons, including severe anxiety. An adult who does not have capacity to consent can be given medical treatment in an emergency, in their best interests. A parent may consent for a young person under 18. If unavailable, in an emergency proceed in the patient s best interest as for an adult. 2. Sedation must have therapeutic intent, e.g. to prevent harm to the patient, other patients, staff or visitors; to permit the administration of other definitive treatment in the patient s best interest; or to relieve distressing symptoms like psychosis, fear or severe anxiety. If there is doubt, consult a senior colleague or a psychiatrist. A section of the Mental Health Act (1983) may need to be applied, but do not allow this to delay treatment which is immediately necessary. Some conflict situations may be managed best by acceding to the patients demands (e.g. to be allowed to leave hospital). 3. Benzodiazepines depress respiration. FLUMAZENIL should be available. Give if respiratory rate is < 10 breaths/minute (200micrograms IV, then 100microg at 60 second intervals, if required, maximum dose 1mg). It is short-acting and may need repeating or infusing (100-400microg/hour). 4. For IM use, LORAZEPAM should be diluted with an equal volume of water for injection or 0.9% Sodium Chloride (Normal Saline), immediately before injection. 5. Combinations of benzodiazepines and antipsychotics have an additive effect allowing smaller doses of each to be used. 6. Never mix LORAZEPAM (or DIAZEPAM) with any other drugs in the same syringe. Give separate injections. 7. PROCYCLIDINE (5mg IM) injection must be available for acute dystonias. Repeat, if necessary, after 20 minutes. Maximum dose 20mg in 24 hours. 8. Avoid phenothiazines or other antipsychotics in acute alcohol withdrawal. There are separate guidelines for non-emergency alcohol withdrawal and detoxification. Oral CHLORDIAZEPOXIDE is the drug of first choice. 9. Use small doses for small people. Required dose of neuroleptic depends on age, body build, physical frailty, co-morbid diagnoses, severity of management problem, previous exposure/response to neuroleptics, skill of nurses. 10. Patients with dementia, especially Lewy body dementia, are particularly prone to sideeffects. If antipsychotics are given at all, very low doses should be used. 11. MIDAZOLAM comes as 10mg in a 5ml ampoule. Dilute with an equal volume of 0.9% Sodium Chloride (Normal Saline) for IV use to make a solution of 1mg/ml. (It also comes as 10mg in 2ml; make sure you have the right one). Normal dose is up to 7.5mg, but in exceptional circumstances more may be used. There are Trust policies on Aggression, Violence and Harassment; Consent; and Restraint which must be observed. This guideline is consistent with these in the emergency situation.